What are the potential eye-related risks of budesonide?
Generally, budesonide belongs to the class of adrenal corticosteroid drugs and is commonly available as a powder inhaler, aerosol, or nasal spray. It is intended for direct application into the nasal cavity. However, improper use may lead to adverse effects such as eye congestion, eye infection, eye allergy, increased intraocular pressure, and dry eye syndrome. Specific analyses are as follows:
1. Eye Congestion
Budesonide is an aerosol medication; if sprayed into the eyes, it can easily irritate the conjunctiva, causing eye redness or congestion.
2. Eye Infection
If budesonide enters the eyes, it may result in ocular infections, typically caused by microorganisms such as fungi, bacteria, or viruses entering the eye.
3. Eye Allergy
Spraying budesonide into the eyes during use may induce drug-induced allergic reactions in the eyes, manifesting as symptoms including itching, swelling, burning sensation, and mucous or filamentous secretions.
4. Increased Intraocular Pressure
Prolonged use of budesonide may cause corneal thinning, leading to persistently elevated intraocular pressure and resulting in symptoms such as decreased vision and halos around lights (chromatopsia).
5. Dry Eye Syndrome
This medication has anti-inflammatory and immunosuppressive properties. Overuse may easily trigger ocular inflammation and immune responses, suppress lacrimal gland function, reduce tear production, and consequently lead to dry eye syndrome, presenting as eye dryness and pain.
Patients are advised to use the medication correctly under a doctor's guidance and should avoid direct contact between the drug and the eyes to prevent irritation and discomfort.